Medication info
Twin On Tablets 80/5 mg

Twin On Tablets 80/5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletTelmisartan Powder 23.9%›334.72mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Korea Chorus Co., Ltd.
Appearance
For domestic use: white or whitish rectangular tablet. For export: a white and light gray bilayer oval tablet that is convex on both sides.
Packaging
30 tablets/box [(10 tablets/Alu-Alu*3)], 30 tablets/bottle
Approval status
Active

MFDS item code 201706875 · Approved 2017.08.29 · Insurance code 647204420

Summary

Main use
Treatment of essential hypertension uncontrolled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this product is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose of the individual components (amlodipine or telmisartan) be adjusted before administering this product. However, direct switching to this product may be considered if blood pressure is not controlled with an individual component, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this product 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ∘ Patients with renal impairment: No dose adjustment is required for patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ∘ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution in Administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
∘ Children: The safety and efficacy of this product have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Korea Chorus Co., Ltd.

Efficacy & effects

Treatment of essential hypertension uncontrolled by monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension who have difficulty controlling blood pressure with amlodipine or telmisartan monotherapy. This drug effectively reduces blood pressure, lowering the risk of cardiovascular complications while assisting in stable blood pressure management. Therefore, it helps in blood pressure control for patients with essential hypertension.

How to take

Adult dose

The recommended dose of this product is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose of the individual components (amlodipine or telmisartan) be adjusted before administering this product. However, direct switching to this product may be considered if blood pressure is not controlled with an individual component, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this product 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ∘ Patients with renal impairment: No dose adjustment is required for patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ∘ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution in Administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

∘ Children: The safety and efficacy of this product have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This drug can cause serious damage to the fetus, especially during the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. This medication should not be administered to patients with certain conditions. For instance, it is contraindicated for individuals allergic to any of its components, pregnant or breastfeeding women, patients with biliary obstructive disease, severe liver impairment, severe heart disease, severe hypotension, shock state, unstable heart failure following acute myocardial infarction, patients with certain genetic issues, and those with diabetes or severe kidney impairment. Use of this drug should be cautious in patients with primary aldosteronism, valvular heart disease, liver disease, gastrointestinal disease, renovascular hypertension, patients on dialysis, and the elderly. Common side effects may include dizziness and swelling in limbs, while rare serious side effects like fainting can occur. Use of this drug should be avoided during pregnancy, and if pregnancy is confirmed, it should be discontinued immediately and replaced with a safe alternative. Due to the risk of hypotension, patients who are dehydrated or have low salt levels should correct their condition before taking this medication, and immediate action should be taken if hypotensive symptoms occur. This medication may increase blood potassium levels, so potassium levels should be monitored regularly, and care should be taken when using potassium supplements or medications containing potassium. Patients with weak kidney function should undergo regular blood tests to check kidney function and electrolyte status while taking this medication. Patients with heart disease should be cautious as this drug may increase the risk of angina or myocardial infarction after taking it. This medication can cause drowsiness or dizziness, so caution is needed when driving or operating dangerous machinery. When taking this medication with others, there is a possibility of interactions, so it is essential to consult a specialist, particularly when combined with certain heart medications, diuretics, non-steroidal anti-inflammatory drugs, or grapefruit juice. It is advisable for breastfeeding women to avoid using this medication. This drug is not recommended for children under 18 years of age as safety and efficacy have not been sufficiently established. Elderly patients may be more sensitive to the drug, so dose adjustment and caution are necessary when using it. In case of overdose, symptoms such as hypotension, cardiac arrhythmias, dizziness, acute renal failure may occur, and immediate medical attention is required.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 99 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylaxis
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory impairment
  • taste disorder
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • hepatic dysfunction
  • liver impairment
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • polymorphic erythema
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • arthritis
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • frequent urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container that blocks light, and the storage temperature should be kept between 1 and 30 degrees Celsius at room temperature. Storing it this way will help maintain the drug's effectiveness for a long time.

Appearance and packaging

Appearance

For domestic use: white or whitish rectangular tablet. For export: a white and light gray bilayer oval tablet that is convex on both sides.

Package unit

30 tablets/box [(10 tablets/Alu-Alu*3)], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.